Binder R, Hwang S P, Ratnasabapathy R, Williams D L
Department of Pharmacological Sciences, University of New York, Stony Brook 11794.
J Biol Chem. 1989 Oct 5;264(28):16910-8.
Degradation intermediates of the estrogen-regulated apolipoprotein (apo) II mRNA were identified by S1 nuclease mapping and primer extension analysis. S1 mapping of poly(A)-RNA detected a series of mRNAs truncated at specific sites in the 3'-noncoding region. Many of these sites were also detected by primer extension analysis indicating that truncated molecules resulted from endonucleolytic cleavage in the 3'-noncoding region. Identical cleavage sites were seen with RNA from estrogen-treated animals or from animals withdrawn from hormone under conditions where apoII mRNA degraded in the slow (t1/2 = 13 h) or rapid (t1/2 = 1.5 h) decay mode. No differences were seen in poly(A) tail length or heterogeneity among these conditions. These results indicate that the estrogen-induced alteration in apoII mRNA turnover does not involve a new pathway of degradation, but, more likely, involves an increased targeting of the mRNA for degradation by a preexisting pathway. These data are consistent with a mechanism in which the initial step in apoII mRNA degradation is an endonucleolytic cleavage in the 3'-noncoding region without prior removal of the poly(A) tail. The endonucleolytic cleavage sites occurred predominantly at 5'-AAU-3' or 5'-UAA-3' trinucleotides found in single-stranded domains in a secondary structure model of the naked mRNA (Hwang, S-P. L., Eisenberg, M., Binder, R., Shelness, G. S., and Williams, D. L. (1989) J. Biol. Chem. 264, 8410-8418). The structure of the 3'-noncoding region in polyribosomal messenger ribonucleoprotein was examined by titrations of liver homogenates with dimethyl sulfate and cobra venom RNase. The results suggest that the typical cleavage site is a 5'-AAU-3' or 5'-UAA-3' trinucleotide in an accessible single-stranded loop domain. Single-stranded domains alone or accessible domains alone are not sufficient for cleavage. Similarly, 5'-AAU-3' or 5'-UAA-3' trinucleotides alone are not sufficient for cleavage. Localization of these trinucleotides to accessible single-stranded domains in the polyribosomal messenger ribonucleoprotein may provide the specificity for cleavage during targeted degradation.
通过S1核酸酶图谱分析和引物延伸分析鉴定了雌激素调节的载脂蛋白(apo)II mRNA的降解中间体。对聚腺苷酸(poly(A))-RNA进行S1图谱分析,检测到一系列在3'-非编码区特定位点截短的mRNA。引物延伸分析也检测到许多这些位点,表明截短分子是由3'-非编码区内的核酸内切酶切割产生的。在apoII mRNA以慢(半衰期t1/2 = 13小时)或快(半衰期t1/2 = 1.5小时)降解模式降解的条件下,来自雌激素处理动物或撤去激素动物的RNA观察到相同的切割位点。在这些条件下,聚腺苷酸尾巴长度或异质性没有差异。这些结果表明,雌激素诱导的apoII mRNA周转变化不涉及新的降解途径,而更可能涉及通过现有途径增加对mRNA的降解靶向。这些数据与一种机制一致,即apoII mRNA降解的初始步骤是在3'-非编码区内的核酸内切酶切割,而无需事先去除聚腺苷酸尾巴。核酸内切酶切割位点主要出现在裸露mRNA二级结构模型单链结构域中的5'-AAU-3'或5'-UAA-3'三核苷酸处(黄,S-P.L.,艾森伯格,M.,宾德,R.,谢尔内斯,G.S.,和威廉姆斯,D.L.(1989年)《生物化学杂志》264,8410 - 8418)。通过用硫酸二甲酯和眼镜蛇毒核糖核酸酶滴定肝脏匀浆,研究了多核糖体信使核糖核蛋白中3'-非编码区的结构。结果表明,典型的切割位点是可及单链环结构域中的5'-AAU-3'或5'-UAA-3'三核苷酸。单独的单链结构域或可及结构域不足以进行切割。同样,单独的5'-AAU-3'或5'-UAA-3'三核苷酸也不足以进行切割。这些三核苷酸在多核糖体信使核糖核蛋白可及单链结构域中的定位可能为靶向降解过程中的切割提供特异性。